- INTCIntel$608BReported
INTCQ2 2008
Intel
View full reportEPS
Estimated
$0.25
Actual
$0.53112.0%
Revenue
Estimated
$8.5B
Actual
$19.1B126.4%
- INTCIntel$608BReported
INTCQ2 2009
Intel
View full reportEPS
Estimated
$0.08
Actual
-$0.07187.5%
Revenue
Estimated
$9.2B
Actual
$8.0B12.5%
- GEGE$335BReported
GEQ4 2008
GE
View full reportEPS
Estimated
$2.94
Actual
$2.804.8%
Revenue
Estimated
$47.5B
Actual
$46.2B2.7%
- GEGE$335BReported
GEQ2 2008
GE
View full reportEPS
Estimated
$4.28
Actual
$7.5275.7%
Revenue
Estimated
$46.8B
Actual
$89.1B90.2%
- GEGE$335BReported
GEQ2 2009
GE
View full reportEPS
Estimated
$1.85
Actual
$1.923.8%
Revenue
Estimated
$34.6B
Actual
$12.9B62.6%
- SCCOSouthern Copper$163BReported
SCCOQ1 2009
Southern Copper
View full reportEPS
Estimated
$0.09
Actual
$0.090.0%
Revenue
Estimated
$622.0M
Actual
$622.0M0.0%
- SCCOSouthern Copper$163BReported
SCCOQ2 2008
Southern Copper
View full reportEPS
Estimated
$0.65
Actual
$1.2693.8%
Revenue
Estimated
$1.6B
Actual
$1.5B6.2%
- SCCOSouthern Copper$163BReported
SCCOQ2 2009
Southern Copper
View full reportEPS
Estimated
$0.18
Actual
$0.2116.7%
Revenue
Estimated
$706.7M
Actual
$824.5M16.7%
- SCCOSouthern Copper$163BReported
SCCOQ4 2007
Southern Copper
View full reportEPS
Estimated
$0.69
Actual
$2.51263.8%
Revenue
Estimated
$2.6B
Actual
$1.3B49.3%
- SCCOSouthern Copper$163BReported
SCCOQ4 2008
Southern Copper
View full reportEPS
Estimated
$0.15
Actual
-$0.13186.7%
Revenue
Estimated
$1.2B
Actual
$449.7M62.1%
- HONHoneywell$148BReported
HONQ2 2008
Honeywell
View full reportEPS
Estimated
$0.94
Actual
$1.8495.7%
Revenue
Estimated
$9.5B
Actual
$18.6B96.0%
- HONHoneywell$148BReported
HONQ4 2008
Honeywell
View full reportEPS
Estimated
$0.97
Actual
$0.970.0%
Revenue
Estimated
$8.7B
Actual
$8.7B0.0%
- HONHoneywell$148BReported
HONQ2 2009
Honeywell
View full reportEPS
Estimated
$0.60
Actual
$0.583.3%
Revenue
Estimated
$7.6B
Actual
$7.6B0.0%
- JNJJohnson & Johnson$556BReported
JNJQ2 2008
Johnson & Johnson
View full reportEPS
Estimated
$1.12
Actual
$2.45118.8%
Revenue
Estimated
$15.6B
Actual
$16.4B5.4%
- JNJJohnson & Johnson$556BReported
JNJQ2 2010
Johnson & Johnson
View full reportEPS
Estimated
$1.12
Actual
$1.163.6%
Revenue
Estimated
$14.8B
Actual
$15.2B2.7%
- JNJJohnson & Johnson$556BReported
JNJQ4 2008
Johnson & Johnson
View full reportEPS
Estimated
$0.92
Actual
$0.986.5%
Revenue
Estimated
$14.9B
Actual
$15.2B2.2%
- COPConocoPhillips$140BReported
COPQ2 2009
ConocoPhillips
View full reportEPS
Estimated
$0.85
Actual
$0.5831.8%
Revenue
Estimated
$31.2B
Actual
$67.9B118.0%
- COPConocoPhillips$140BReported
COPQ2 2008
ConocoPhillips
View full reportEPS
Estimated
$3.45
Actual
$6.1879.1%
Revenue
Estimated
$70.7B
Actual
$129.9B83.7%
- MOAltria$120BReported
MOQ2 2008
Altria
View full reportEPS
Estimated
$0.45
Actual
$1.62260.0%
Revenue
Estimated
$4.9B
Actual
$5.1B2.2%
- MOAltria$120BReported
MOQ2 2009
Altria
View full reportEPS
Estimated
$0.47
Actual
$0.494.3%
Revenue
Estimated
$6.3B
Actual
$6.7B6.4%
- MOAltria$120BReported
MOQ4 2008
Altria
View full reportEPS
Estimated
$0.37
Actual
$0.3310.8%
Revenue
Estimated
$4.7B
Actual
$1.3B73.0%
- CVSCVS Health$119BReported
CVSQ4 2008
CVS Health
View full reportEPS
Estimated
$0.69
Actual
$0.664.3%
Revenue
Estimated
$23.8B
Actual
$24.1B1.5%
- CVSCVS Health$119BReported
CVSQ2 2009
CVS Health
View full reportEPS
Estimated
$0.64
Actual
$0.615.0%
Revenue
Estimated
$24.5B
Actual
$24.9B1.6%
- CVSCVS Health$119BReported
CVSQ2 2008
CVS Health
View full reportEPS
Estimated
$0.60
Actual
$1.0676.7%
Revenue
Estimated
$21.1B
Actual
$42.5B100.9%
- GDGeneral Dynamics$94.4BReported
GDQ2 2008
General Dynamics
View full reportEPS
Estimated
$1.44
Actual
$3.04111.1%
Revenue
Estimated
$6.6B
Actual
$14.3B117.7%
- GDGeneral Dynamics$94.4BReported
GDQ4 2008
General Dynamics
View full reportEPS
Estimated
$1.59
Actual
$1.580.6%
Revenue
Estimated
$7.7B
Actual
$7.9B1.9%
- GDGeneral Dynamics$94.4BReported
GDQ2 2009
General Dynamics
View full reportEPS
Estimated
$1.57
Actual
$1.601.9%
Revenue
Estimated
$7.9B
Actual
$8.1B2.5%
- XOMExxonMobil$609BReported
XOMQ2 2009
ExxonMobil
View full reportEPS
Estimated
$1.02
Actual
$0.8219.6%
Revenue
Estimated
$87.6B
Actual
$74.5B15.0%
- XOMExxonMobil$609BReported
XOMQ2 2008
ExxonMobil
View full reportEPS
Estimated
$2.52
Actual
$4.2769.4%
Revenue
Estimated
$148.5B
Actual
$138.1B7.0%
- XOMExxonMobil$609BReported
XOMQ4 2008
ExxonMobil
View full reportEPS
Estimated
$1.45
Actual
$1.578.3%
Revenue
Estimated
$75.3B
Actual
$84.7B12.5%
- GSGoldman Sachs$297BReported
GSQ2 2009
Goldman Sachs
View full reportEPS
Estimated
$3.54
Actual
$10.96209.6%
Revenue
Estimated
$10.9B
Actual
$13.8B26.2%
- GSGoldman Sachs$297BReported
GSQ2 2008
Goldman Sachs
View full reportEPS
Estimated
$1.71
Actual
$8.18378.4%
Revenue
Estimated
$12.9B
Actual
$9.4B26.8%
- GSGoldman Sachs$297BReported
GSQ4 2008
Goldman Sachs
View full reportEPS
Estimated
$1.64
Actual
-$5.41429.9%
Revenue
Estimated
$7.9B
Actual
-$4.6B157.8%
- TAT&T$173BReported
TQ2 2009
AT&T
View full reportEPS
Estimated
$0.51
Actual
$0.557.8%
Revenue
Estimated
$28.9B
Actual
$30.6B5.9%
- TAT&T$173BReported
TQ4 2008
AT&T
View full reportEPS
Estimated
$0.65
Actual
$0.4136.9%
Revenue
Estimated
$31.0B
Actual
$31.1B0.4%
- GILDGilead Sciences$169BReported
GILDQ4 2008
Gilead Sciences
View full reportEPS
Estimated
$0.27
Actual
$0.61125.9%
Revenue
Estimated
$1.3B
Actual
$1.4B11.1%
- GILDGilead Sciences$169BReported
GILDQ2 2008
Gilead Sciences
View full reportEPS
Estimated
$0.24
Actual
$1.00316.7%
Revenue
Estimated
$1.3B
Actual
$2.5B90.2%
- GILDGilead Sciences$169BReported
GILDQ2 2009
Gilead Sciences
View full reportEPS
Estimated
$0.31
Actual
$0.63103.2%
Revenue
Estimated
$1.5B
Actual
$1.6B12.9%
- SBUXStarbucks$115BReported
SBUXQ4 2008
Starbucks
View full reportEPS
Estimated
$0.07
Actual
$0.0192.9%
Revenue
Estimated
$3.5B
Actual
$2.5B28.6%
- SBUXStarbucks$115BReported
SBUXQ3 2008
Starbucks
View full reportEPS
Estimated
$0.09
Actual
$0.21133.3%
Revenue
Estimated
$2.9B
Actual
$2.6B11.1%
- SBUXStarbucks$115BReported
SBUXQ3 2009
Starbucks
View full reportEPS
Estimated
$0.09
Actual
$0.27200.0%
Revenue
Estimated
$1.8B
Actual
$2.4B33.3%
- CVXChevron$365BReported
CVXQ2 2008
Chevron
View full reportEPS
Estimated
$3.03
Actual
$2.914.0%
Revenue
Estimated
$84.6B
Actual
$83.0B1.9%
- CVXChevron$365BReported
CVXQ2 2009
Chevron
View full reportEPS
Estimated
$0.95
Actual
$0.887.4%
Revenue
Estimated
$43.3B
Actual
$40.2B7.1%
- UNHUnitedHealth$347BReported
UNHQ4 2008
UnitedHealth
View full reportEPS
Estimated
$0.78
Actual
$0.6023.1%
Revenue
Estimated
$20.3B
Actual
$20.5B0.5%
- UNHUnitedHealth$347BReported
UNHQ2 2008
UnitedHealth
View full reportEPS
Estimated
$0.64
Actual
$1.0868.8%
Revenue
Estimated
$19.1B
Actual
$40.6B112.1%
- UNHUnitedHealth$347BReported
UNHQ2 2009
UnitedHealth
View full reportEPS
Estimated
$0.70
Actual
$0.745.7%
Revenue
Estimated
$20.6B
Actual
$21.7B5.0%
- MCDMcDonald's$197BReported
MCDQ2 2008
McDonald's
View full reportEPS
Estimated
$0.86
Actual
$1.88118.6%
Revenue
Estimated
$5.6B
Actual
$11.7B110.3%
- MCDMcDonald's$197BReported
MCDQ4 2008
McDonald's
View full reportEPS
Estimated
$0.83
Actual
$0.897.2%
Revenue
Estimated
$5.3B
Actual
$5.6B4.8%
- MCDMcDonald's$197BReported
MCDQ2 2009
McDonald's
View full reportEPS
Estimated
$0.97
Actual
$1.003.1%
Revenue
Estimated
$5.6B
Actual
$5.6B0.0%
- APHAmphenol$182BReported
APHQ2 2008
Amphenol
View full reportEPS
Estimated
$0.15
Actual
$0.59293.3%
Revenue
Estimated
$792.2M
Actual
$846.8M6.9%
- APHAmphenol$182BReported
APHQ2 2009
Amphenol
View full reportEPS
Estimated
$0.11
Actual
$0.22100.0%
Revenue
Estimated
$654.1M
Actual
$685.2M4.8%
- APHAmphenol$182BReported
APHQ4 2008
Amphenol
View full reportEPS
Estimated
$0.13
Actual
$0.28119.2%
Revenue
Estimated
$674.4M
Actual
$755.3M12.0%
- PFEPfizer$149BReported
PFEQ2 2009
Pfizer
View full reportEPS
Estimated
$0.47
Actual
$0.3329.8%
Revenue
Estimated
$10.8B
Actual
$11.0B2.1%
- PFEPfizer$149BReported
PFEQ2 2008
Pfizer
View full reportEPS
Estimated
$0.54
Actual
$0.8353.7%
Revenue
Estimated
$11.9B
Actual
$12.1B1.9%
- PFEPfizer$149BReported
PFEQ4 2008
Pfizer
View full reportEPS
Estimated
$0.59
Actual
$0.0493.2%
Revenue
Estimated
$11.2B
Actual
$12.3B10.2%
- BACBank of America$360BReported
BACQ2 2009
Bank of America
View full reportEPS
Estimated
$0.28
Actual
$0.3110.7%
Revenue
Estimated
$27.8B
Actual
$32.8B17.9%
- BACBank of America$360BReported
BACQ2 2008
Bank of America
View full reportEPS
Estimated
$0.53
Actual
$0.9579.2%
Revenue
Estimated
$15.0B
Actual
$37.5B149.5%
- MSMorgan Stanley$321BReported
MSQ1 2009
Morgan Stanley
View full reportEPS
Estimated
—
Actual
-$0.57
Revenue
Estimated
—
Actual
$2.9B
- MSMorgan Stanley$321BReported
MSQ2 2009
Morgan Stanley
View full reportEPS
Estimated
-$0.49
Actual
-$1.14132.7%
Revenue
Estimated
$4.9B
Actual
$5.4B10.0%
- MSMorgan Stanley$321BReported
MSQ4 2008
Morgan Stanley
View full reportEPS
Estimated
$0.00
Actual
-$8.21
Revenue
Estimated
$0.00
Actual
-$9.8B
- WFCWells Fargo$235BReported
WFCQ2 2009
Wells Fargo
View full reportEPS
Estimated
$0.34
Actual
$0.5870.6%
Revenue
Estimated
$18.0B
Actual
$22.5B24.9%
- WFCWells Fargo$235BReported
WFCQ2 2008
Wells Fargo
View full reportEPS
Estimated
$0.50
Actual
$1.13126.0%
Revenue
Estimated
$10.8B
Actual
$11.5B6.0%
- WFCWells Fargo$235BReported
WFCQ4 2008
Wells Fargo
View full reportEPS
Estimated
$0.33
Actual
-$0.93381.8%
Revenue
Estimated
$4.0B
Actual
$9.8B148.2%
- ABTAbbott$150BReported
ABTQ4 2008
Abbott
View full reportEPS
Estimated
$1.06
Actual
$0.996.6%
Revenue
Estimated
$8.0B
Actual
$8.0B0.0%
- ABTAbbott$150BReported
ABTQ2 2008
Abbott
View full reportEPS
Estimated
$0.79
Actual
$0.868.9%
Revenue
Estimated
$6.9B
Actual
$7.3B6.3%
- ABTAbbott$150BReported
ABTQ2 2009
Abbott
View full reportEPS
Estimated
$0.89
Actual
$0.836.7%
Revenue
Estimated
$7.5B
Actual
$7.5B0.0%
- CBChubb$123BReported
CBQ2 2008
Chubb
View full reportEPS
Estimated
$1.90
Actual
$3.3174.2%
Revenue
Estimated
$3.0B
Actual
$6.9B131.3%
- CBChubb$123BReported
CBQ2 2009
Chubb
View full reportEPS
Estimated
$1.94
Actual
$1.5918.0%
Revenue
Estimated
$3.0B
Actual
$3.5B17.0%